Intelligence · Drug directory
EMA-Approved Drugs Directory
European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.
Quick answer
EMA-approved drugs: NovaPharmaNews tracks 931 pharmaceutical drugs in this segment. European Medicines Agency approved medicines with EPAR-derived status, INN profiles, and competitive intelligence links.
-
garadacimab
ANDEMBRY
B06AC07 -
gefapixant
LYFNUA
R05DB29 -
germanium (68ge) chloride
GALENVITA
V09X -
gilteritinib
XOSPATA Astellas Pharma Inc
L01EX13 -
givinostat
DUVYZAT
M09AX14 -
glasdegib
DAURISMO
L01XX63 -
glibenclamide
DAONIL Sanofi-aventis Healthcare Pty Ltd
A10BB01 -
glofitamab
COLUMVI Hoffmann-La Roche
L01FX28 -
glycopyrronium
AXHIDROX Novartis Pharmaceuticals
R03AL07 -
glycopyrronium bromide
ENUREV BREEZHALER
R03BB06 -
gozetotide
LOCAMETZ
V09I -
hepatitis a (inactivated) and hepatitis b (rdna) (hab) vaccine (adsorbed)
AMBIRIX
J07BC20 -
hepatitis b (rdna) vaccine (adjuvanted, adsorbed)
FENDRIX
J07BC01 -
hepatitis b surface antigen
HEPLISAV B
J07BC01 -
hepatitis b vaccine (recombinant dna)
HBVAXPRO
J07BC01 -
herpes zoster vaccine (recombinant, adjuvanted)
SHINGRIX
J07BK03 -
histamine dihydrochloride
CEPLENE
L03AX14 -
human coagulation factor viii / human von willebrand factor
VONCENTO
B02BD06 -
human coagulation factor x
COAGADEX
B02BD13 -
human hepatitis b immunoglobulin
ZUTECTRA
J06BB04 -
human insulin (rdna)
ACTRAPID
A10AB01 -
human normal immunoglobulin (ivig)
PRIVIGEN
J06BA02 -
human normal immunoglobulin (scig)
HIZENTRA
J06BA01 -
human papillomavirus 9-valent vaccine (recombinant, adsorbed)
GARDASIL 9
J07BM03
Frequently asked questions
How many ema approved drugs are listed?
931 drug profiles match this regulatory segment in our published index.
Where does approval data come from?
Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.